Advances in gene therapy in humans: Basic concepts and a historical journey

被引:0
作者
Encina Silva, Gonzalo [1 ,2 ]
机构
[1] Univ Desarrollo Clin Alemana, Ctr Genet & Genom, Inst Ciencias & Innovac Med, Fac Med, Santiago, Chile
[2] Biosoluc UDD, Santiago, Chile
来源
REVISTA MEDICA CLINICA LAS CONDES | 2022年 / 33卷 / 02期
关键词
Gene Therapy; Genetic Vector; Gene Transfer Technique; Adeno-associated Virus; CRISPR; LENTIVIRAL VECTOR; VIRAL VECTORS; T-CELLS; TRANSDUCTION; ENGRAFTMENT; DELIVERY; PROGRESS;
D O I
10.1016/j.rmclc.2022.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene therapy has promised to revolutionize medicine since the concept of treating disease by using viruses to replace damaged DNA in a patient with corrected DNA was introduced in the 1970s. The first working model was tested in mice, in the 1980s. In the 1990s, gene therapy strategies began to be used to treat some immune and nutritional deficiencies, with limited success. Later, in 1999, a patient died in a gene therapy trial due to complications associated with a severe immune response against the gene vector. This tragedy temporarily brought the entire field to a halt. Research recovered slowly but steadily, until 2012, when the discovery of CRISPR, a technology that enables easy and precise modifications of human genes, strongly reinvigorated the entire field. This review presents the fundamentals of gene therapy and a historical journey with the main milestones that occurred in the last 50 years.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 65 条
[1]   Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products [J].
Aiuti, Alessandro ;
Roncarolo, Maria Grazia ;
Naldini, Luigi .
EMBO MOLECULAR MEDICINE, 2017, 9 (06) :737-740
[2]   Nonviral Gene Delivery: Principle, Limitations, and Recent Progress [J].
Al-Dosari, Mohammed S. ;
Gao, Xiang .
AAPS JOURNAL, 2009, 11 (04) :671-681
[3]  
[Anonymous], NEW STUDY HEMOPHILIA
[4]  
[Anonymous], 2019, J GENE MED VECTORS U
[5]   What's new in clinical CRISPR? [J].
Arnold, Carrie .
NATURE MEDICINE, 2021, 27 (02) :184-185
[6]   T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS [J].
BLAESE, RM ;
CULVER, KW ;
MILLER, AD ;
CARTER, CS ;
FLEISHER, T ;
CLERICI, M ;
SHEARER, G ;
CHANG, L ;
CHIANG, YW ;
TOLSTOSHEV, P ;
GREENBLATT, JJ ;
ROSENBERG, SA ;
KLEIN, H ;
BERGER, M ;
MULLEN, CA ;
RAMSEY, WJ ;
MUUL, L ;
MORGAN, RA ;
ANDERSON, WF .
SCIENCE, 1995, 270 (5235) :475-480
[7]   GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS [J].
BORDIGNON, C ;
NOTARANGELO, LD ;
NOBILI, N ;
FERRARI, G ;
CASORATI, G ;
PANINA, P ;
MAZZOLARI, E ;
MAGGIONI, D ;
ROSSI, C ;
SERVIDA, P ;
UGAZIO, AG ;
MAVILIO, F .
SCIENCE, 1995, 270 (5235) :470-475
[8]  
[Boyer Herbert W. Science History Institute Science History Institute], webpage
[9]  
Caccomo S, 2019, FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality
[10]   Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy [J].
Cartier, Nathalie ;
Hacein-Bey-Abina, Salima ;
Bartholomae, Cynthia C. ;
Veres, Gabor ;
Schmidt, Manfred ;
Kutschera, Ina ;
Vidaud, Michel ;
Abel, Ulrich ;
Dal-Cortivo, Liliane ;
Caccavelli, Laure ;
Mahlaoui, Nizar ;
Kiermer, Veronique ;
Mittelstaedt, Denice ;
Bellesme, Celine ;
Lahlou, Najiba ;
Lefrere, Francois ;
Blanche, Stephane ;
Audit, Muriel ;
Payen, Emmanuel ;
Leboulch, Philippe ;
l'Homme, Bruno ;
Bougneres, Pierre ;
Von Kalle, Christof ;
Fischer, Alain ;
Cavazzana-Calvo, Marina ;
Aubourg, Patrick .
SCIENCE, 2009, 326 (5954) :818-823